Jim Collins

Jim Collins is a senior executive in the global biosciences industry, recognized for leading innovation and commercial operations at DuPont Industrial Biosciences. As president of this business, Collins has overseen portfolios in enzymes, biomaterials, biofuels, and advanced biological solutions applied across food, agriculture, energy, and consumer products. In this capacity, he has managed strategy, research and development integration, and go-to-market execution in markets where biotechnology and industrial-scale manufacturing converge, establishing DuPont as a significant entity in sustainable, bio-based technologies.

Collins has directed DuPont Industrial Biosciences in translating scientific advancements into commercially viable products that enhance process efficiency and reduce environmental impact. He has worked at the intersection of scientists, engineers, and global customers, guiding investments in research platforms and new applications for industrial enzymes and renewable materials. This work has required technical expertise and the ability to communicate complex biological and chemical concepts to business leaders, regulators, and partners worldwide.

Collins regularly participates in industry forums, customer events, and internal leadership programs, addressing topics such as innovation management, sustainability, and the evolution of industrial biotechnology. Drawing on his experience managing a diversified global business, he discusses scaling laboratory discoveries to full production, managing risk in emerging technologies, and building cross-functional teams for competitive performance in dynamic markets. His executive background and understanding of both scientific and commercial aspects of biosciences provide insight for audiences interested in the impact of biology on industry transformation.

Throughout his career, Collins has addressed the challenges of transforming legacy chemical and materials portfolios toward sustainable, bio-based solutions. He has been involved in organizational change, portfolio realignment, and the integration of new technologies and talent, often amid evolving regulatory requirements and customer expectations. These experiences, combined with his leadership at DuPont Industrial Biosciences, highlight his expertise in guiding complex organizations through technological transitions and navigating the dynamics of large-scale innovation.